Building a deeper Harbour
How Harbour BioMed plans pipeline growth after GIC-led $85 million series B
With an $85 million B round in hand, Harbour BioMed plans to advance newly in-licensed clinical programs while simultaneously building its pipeline through its internal platform and co-discovery deals.
Singapore sovereign wealth fund GIC led the round, which closed on Aug. 27. Fellow new